Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEUROBO-PHARMACEUTICALS-I-28734724/news/NeuroBo-Pharmaceuticals-Receives-Safety-Review-Committee-Approval-to-Continue-With-Its-Phase-2a-Clin-46159856/?utm_source=whatsapp&utm_medium=social&utm_campaign=share